Incorrect Byline and Figure Terminology: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial

Michelle L. O'Donoghue, Eugene Braunwald, Harvey D. White, Dylan P. Steen, Mary Ann Lukas, Elizabeth Tarka, P. Gabriel Steg, Judith S. Hochman, Christoph Bode, Aldo P. Maggioni, Kyung Ah Im, Jennifer B. Shannon, Richard Y. Davies, Sabina A. Murphy, Sharon E. Crugnale, Stephen D. Wiviott, Marc P. Bonaca, David F Watson, W. Douglas Weaver, Patrick W. SerruysChristopher P. Cannon, SOLID-TIMI 52 Investigators, P. E. Aylward, S. A. Chen, B. Lewis, J. Anderson, M. Freeman, R. Lehman, P. Roberts-Thomson, M. Nguyen, X. Li, D. Weber, J. Elliott, N. Harrison, R. Stewart, Y. K. Wong, A. Ahmed, S. Ahmed, J. Anderson, S. Baker, J. Chin, R. Foreman, D. Lee, P. Morris, A. Smith, J. Thomas, D. Wilson

    Research output: Contribution to journal › Comment/debate

    17 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Incorrect Byline and Figure Terminology: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial'. Together they form a unique fingerprint.
    Sort by

    Pharmacology, Toxicology and Pharmaceutical Science